
Through twenty years of challenges and achievements, are testament to FOHOW's continuous breakthroughs in innovation
Email Marketing
Social Marketing
Market Research
SEO Optimization
Development History
Since its establishment, Fohow has always adhered to its original aspiration, forging ahead through challenges, continuously innovating in R&D, optimizing production processes, and expanding market territories, injecting sustained momentum into industry development with stable product quality and solid technical accumulation.

1999
Fohow founder Mr. Yu Fei established Yu De Health Food Production Base in Foshan, Guangdong

2000
FOHOW established a set of health food production and testing standards that comply with pharmaceutical production standards, ensuring product quality

2001
Fohow Health Research Institute was established, led by Professor Tang Youzhi, a master of traditional Chinese medicine, who developed Fohow Oral Liquid with his exclusive formula

2002
Fohow health products went overseas, successfully exported to the Philippines, Thailand, Hong Kong, Taiwan and other regions

2003
Flagship products Fohow Cordyceps Oral Liquid, Sanbao Oral Liquid, and Sanqing Oral Liquid were rated as national quality trustworthy products, and Fohow High-Tech Group was rated as a national quality service consumer satisfaction enterprise

2003
Flagship products Fohow Cordyceps Oral Liquid, Sanbao Oral Liquid, and Sanqing Oral Liquid were rated as national quality trustworthy products

2003
Fohow High-Tech Group was rated as a national quality service consumer satisfaction enterprise

2004
The group established the "Three Principles of Product Development" and "Three Health Preservation Theories" were officially implemented

2004
World champion Mr. Guo Yuehua became Fohow product spokesperson

2005
Zhuhai Yupintang Production Base officially commenced production

2006
FOHOW brand officially launched globally

2007
Opened the first overseas branch - Moscow Branch, officially entering overseas markets

2008
Under the initiative of Mr. Yu Fei, Fohow Hope Foundation was established, dedicated to improving the lives of orphaned and disabled children worldwide

2009
FOHOW African market launched

2009
New products obtained certifications from multiple countries

2010
FOHOW Group Senior Leadership Committee was established

2010
FOHOW business expanded to 38 countries

2011
In Moscow, Russia, the group jointly held an international acupuncture symposium with the World Federation of Acupuncture-Moxibustion Societies to promote traditional Chinese medicine health culture

2012
Tianjin production base phase one officially commenced production

2012
Signed Lithuanian famous athlete, Olympic men's single sculls silver medalist Mr. Yevgeny Shuklin as product spokesperson

2013
Ms. Alla Goffman became FOHOW Group's first Fohow Ambassador. As of August 2025, we have 21 Fohow Ambassadors

2014
The group became a member of the World Economic Forum's Global Growth Companies, and founder Yu Fei was invited to attend the Davos Forum

2014
Tianjin production base phase two officially commenced construction

2014
Signed Russian famous athlete, archery Olympic and world champion Mr. Tuchinov as FOHOW product spokesperson

2015
Company business expanded to 68 countries globally

2015
Tasbulat Mirgaliyev became Fohow Ambassador

2016
FOHOW+ cross-border e-commerce officially established

2016
Henan Nanyang production base established

2017
Fohow International Business School officially established

2017
Traditional Chinese Medicine Culture International Forum successfully held in Poland and Moscow

2017
The group became a member of the World Federation of Acupuncture-Moxibustion Societies

2017
Global overseas market 10th anniversary celebration

2018
The group held its first luxury cruise tour, with 5,000 distributor partners celebrating together

2018
Signed Lithuanian famous athlete, world K1 kickboxing 95kg champion Sergey Maslaboyev as product spokesperson

2019
Acquired and took over Zhuhai Liga Industrial Park, held groundbreaking ceremony for Zhuhai new headquarters

2019
Participated in the 23rd St. Petersburg International Economic Forum and the 2019 Dalian Summer Davos Forum

2020
Group founder and Fohow Hope Foundation Chairman Mr. Yu Fei donated pandemic prevention materials to multiple domestic and international locations

2020
The group won the "Asia Brand Top 500 in 2020" title, and Mr. Yu Fei received the "2020 China (Industry) Brand Top Ten Leading Figures" honor

2021
Uloldecai became FOHOW's first Crown Ambassador. As of July 2025, we have 2 Crown Ambassadors

2022
Global overseas market 15th anniversary celebration

2022
Launched new peptide series products

2023
FOHOW Zhuhai new headquarters industrial park completed

2024
The group pioneered the "Three Modernizations of Traditional Chinese Medicine" development concept, hundreds of experts gathered to hold the first Traditional Chinese Medicine Three Modernizations Forum

2024
Established the Research Institute of "Three Modernizations" of Traditional Chinese Medicine, achieving a series of innovative results

2024
Further expanded global markets, attracting visits from Nigerian kings, French academicians and other friends, promoting traditional Chinese medicine culture worldwide

2025
Led by Qihuang Scholar Professor Miao Mingsan, jointly established the Traditional Chinese Medicine Formula Essential Oil Laboratory with Henan University of Traditional Chinese Medicine, jointly developing innovative traditional Chinese medicine health products such as essential oil energy patches

2025
Joint venture with Japan Heritage Group to establish Fohow Pharmaceutical Japan Co., Ltd., launching the construction of the Japanese base

2025
Invested 300 million US dollars to create a traditional Chinese medicine culture ecological industrial park in Henan Province, China

2025
Cooperated with Sun Yat-sen University to establish the Joint Development Laboratory for Gut Microbiome in Longevity Populations

2025
Cooperated with China Academy of Chinese Medical Sciences to jointly launch the "Sleep Disorder Multimodal Disease-Specific Intelligent Model" R&D project